Press release
Antibody Drug Conjugates Market 2018 Analyzed by Top Key Players Astellas Pharma / Agensys, Progenics Pharmaceuticals, Mersana Therapeutics, Synthon, Heidelberg Pharma, and Oxford BioTherapeutics.
According to the report of Research Cosmos, the Antibody Drug Conjugates Market is poised to reach US$ 18.1 Billion by 2022
Global Antibody Drug Conjugates Market Overview:
Antibody drug conjugates include three parts, primarily an antibody specific for binding, a cytotoxic agent designed to kill the target cancer cells and a chemical binding agent to bind the cytotoxic agent to the antibody. These drug conjugates are considered the new era of therapeutic agents. The combined effect of selecting specific cell types and the ability to kill cytotoxic drugs makes this drug an ideal conjugate for the treatment of several cancers. The success of this technology has only been possible with the technological progress increasing.
The potential of a cytotoxic drug conjugate incorporated in the antibody increases 100 to 1000 times more than the potential of a cytotoxic drug when acting alone. Currently the main conjugated antibody being tested Brentuximab clembatumumab (CDX-011), a monoclonal antibody-drug conjugate developed by Celldex Therapeutics Inc. Other drugs in clinical trials include the Polatuzumab brentuximab Ravtansine (BT-062), developed by Biotest; guanylyl cyclase C against / anti-GCC ADC developed by Takeda; Millennium, anti-PSMA ADC Therapeutics developed by Pharmaceutical Progenics; Coltuximab Ravtansine (SAR3419) developed by Sanofi Pinatuzumab brentuximab and brentuximab Lifastuzumab (RG7599) developed by Roche / Genentech.
Browse report brief and TOC @ https://www.researchcosmos.com/reports/global-antibody-drug-conjugates-market-outlook-2022-trends-and-developments/2425846
Global Antibody Drug Conjugates Market Drivers and restrictions:
The advancement of medical technology is driving the world market for antibody conjugates. In addition, the increase in cancer cases, the increase in the obese population and the aging of the population are determining factors of the market. Moreover, preclinical research, the increasing research activities on antibody therapies, more research on advanced drug discoveries, increasing research on oncology diseases, the rising collaboration between research institutes, and biopharmaceuticals and biotechnology companies are acting as a fuel to the market and are anticipated to drive the market of antibody drug conjugates within the forecast period. Nevertheless, the high cost of the procedures and the lack of funds could be the impediments to growth in this market.
Geographical segmentation:
North America have dominated the world market for drug antibody conjugates due to technological innovation, manufacturing processes of progress and the contribution of nanotechnology in the development of drug-conjugated antibodies (ADCs). There are only three antibody drug conjugates that have received approval from the Food and Drug Administration (FDA). The United States is the largest market among other countries such as Mexico, Canada and others. Although this technology is developed by many of the big pharmaceutical companies, the success rate is the development of a much smaller ADC and it is one of the very few companies. The European antibody conjugate market is the second largest market followed by the Asia Pacific region. Asia Pacific is the emerging market in the global market of anti-antibody conjugates. Growing consumer awareness and growing government initiatives are driving the market for antibody conjugates in this region. There are many products under the pipeline. These developments are carried out under license agreements.
Request free sample @ https://www.researchcosmos.com/request/global-antibody-drug-conjugates-market-outlook-2022-trends/2425846
Key Players In Global Antibody Drug Conjugates Market
The leading contributors to the market are Seattle Genetics (USA) Immunogen, Inc. (USA), Roche Holding AG (Switzerland), Genentech (USA), Concortis Biotherapeutics (United States), Agensys, Inc. (United States), Antikor (United Kingdom), Immunomedics (USA), Pfizer Inc. (United States), Celldex Therapeutics (USA), Millennium Pharmaceuticals (USA), Abbvie Inc. (United States), Bayer HealthCare (Germany), Astellas Pharma / Agensys (Japan), Progenics Pharmaceuticals (USA), Mersana Therapeutics (United States), Synthon (United States), Heidelberg Pharma (Germany), and Oxford BioTherapeutics (United States).
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
LinkedIn - https://www.linkedin.com/company/market-research-cosmos
Twitter - https://twitter.com/researchcosmos
Google+ - https://plus.google.com/109756852849129986268
Facebook - https://www.facebook.com/researchcosmos/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Drug Conjugates Market 2018 Analyzed by Top Key Players Astellas Pharma / Agensys, Progenics Pharmaceuticals, Mersana Therapeutics, Synthon, Heidelberg Pharma, and Oxford BioTherapeutics. here
News-ID: 1282038 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
